Adipocyte-derived players in hematologic tumors: useful novel targets?

Jöhrer, K; Ploner, C; Thangavadivel, S; Wuggenig, P; Greil, R; Expert Opin Biol Ther. 2015; 15(1):61-77

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.

Dittrich, C; Fridrik, MA; Koenigsberg, R; Lee, C; Goeldner, RG; Hilbert, J; Greil, R; Invest New Drugs. 2015; 33(2):409-422

Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians.

Stadlmayr, A; Aigner, E; Huber-Schönauer, U; Niederseer, D; Zwerina, J; Husar-Memmer, E; Hohla, F; Schett, G; Patsch, W; Datz, C; Acta Diabetol. 2015; 52(1):39-46

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.

Melchardt, T; Weiss, L; Hufnagl, C; Neureiter, D; Kemmerling, R; Morre, P; Boekstegers, A; Hopfinger, G; Auberger, J; Steinkirchner, S; Pleyer, L; Greil, R; Egle, A; Leuk Lymphoma. 2015; 56(2):353-360

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff, AS; Ilhan-Mutlu, A; Dinhof, C; Magerle, M; Hackl, M; Widhalm, G; Hainfellner, JA; Dieckmann, K; Pichler, J; Hutterer, M; Melchardt, T; Bartsch, R; Zielinski, CC; Birner, P; Preusser, M; Neuropathol Appl Neurobiol. 2015; 41(2):e41-e55

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions.

Hinterseer, E; Stiefel, O; Neureiter, D; Kandler, G; Vogt, S; Hutter, J; Strasser, G; Greil, R; Hartmann, TN; Hopfinger, G; Leuk Lymphoma. 2015; 56(8):2465-2467

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Blank, PR; Filipits, M; Dubsky, P; Gutzwiller, F; Lux, MP; Brase, JC; Weber, KE; Rudas, M; Greil, R; Loibl, S; Szucs, TD; Kronenwett, R; Schwenkglenks, M; Gnant, M; Pharmacoeconomics. 2015; 33(2):17-90

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.

Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A; Br J Haematol. 2015; 168(2):239-245

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

Burgstaller, S; Bettelheim, P; Krieger, O; Machherndl-Spandl, S; Nösslinger, T; Pleyer, L; Sill, H; Sperr, WR; Stauder, R; Valent, P; Pfeilstöcker, M; Wien Klin Wochenschr. 2015; 127(1-2):12-15

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.

Ludwig, H; Greil, R; Masszi, T; Spicka, I; Shpilberg, O; Hajek, R; Dmoszynska, A; Paiva, B; Vidriales, MB; Esteves, G; Stoppa, AM; Robinson, D; Chaturvedi, S; Ataman, O; Enny, C; Feng, H; van de Velde, H; Viterbo, L; Br J Haematol. 2015; 171(3):3-54